Applying Hsp104 to protein-misfolding disorders

Biochemistry and Cell Biology

Volumn 88, Issue 1, 2010, Pages 1-13

  Vashist, Shilpa ^a   Cushman, Mimi ^a   Shorter, James ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AAA+ protein; Amyloid; Hsp104; Oligomer; Prion

Indexed keywords

AAA+ PROTEIN; ALZHEIMER'S DISEASE; AMYLOID; AMYLOIDOGENESIS; ATP BINDING; DISAGGREGATION; DISORDERED PROTEINS; DOPAMINERGIC NEURONS; ENVIRONMENTAL STRESS; HSP70 CHAPERONES; IN-PLANTS; METAZOA; MISFOLDING; NEURODEGENERATIVE; ORTHOLOGUES; PARKINSON'S DISEASE; PHENOTYPIC VARIATIONS; PROTEIN DISAGGREGATION; RENATURATION; SUBSTANTIA NIGRA; SYNUCLEIN; THERAPEUTIC AGENTS;

GLYCOPROTEINS; NEURONS; OLIGOMERS; YEAST;

PROTEINS;

ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; HEAT SHOCK PROTEIN 104; OLIGOMER; PRION PROTEIN;

ALZHEIMER DISEASE; BACTERIUM; CONFERENCE PAPER; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL STRESS; FUNGUS; METAZOON; NONHUMAN; ORTHOLOGY; PARKINSON DISEASE; PLANT; PROTEIN AGGREGATION; PROTEIN FOLDING; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; ANIMALS; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; PRIONS; PROTEIN DENATURATION; PROTEIN FOLDING; RATS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

FUNGI; METAZOA; RATTUS;

EID: 75349089072     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O09-121     Document Type: Conference Paper

References (159)

1. Alberti, S., Halfmann, R., King, O., Kapila, A., and Lindquist, S. 2009. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell, 137(1): 146-158. doi:10.1016/j.cell.2009.02. 044. PMID:19345193.
2. Anfinsen, C.B. 1973. Principles that govern the folding of protein chains. Science, 181(96): 223-230. doi:10.1126/science.181. 4096.223. PMID:4124164.
3. Arimon, M., Grimminger, V., Sanz, F., and Lashuel, H.A. 2008. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils. J. Mol. Biol. 384(5): 1157-1173. doi:10.1016/j.jmb.2008. 09.063. PMID:18851977.
4. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., and Finkbeiner, S. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431(7010): 805-810. doi:10.1038/ nature02998. PMID:15483602.
5. Bainbridge, J.W., Smith, A.J., Barker, S.S., Robbie, S., Henderson, R., Balaggan, K., et al. 2008. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358(21): 2231-2239. doi:10.1056/NEJMoa0802268. PMID: 18441371.
6. Balch, W.E., Morimoto, R.I., Dillin, A., and Kelly, J.W. 2008. Adapting proteostasis for disease intervention. Science, 319(5865): 916-919. doi:10.1126/science.1141448. PMID: 18276881.
7. Bao, Y.P., Cook, L.J., O'Donovan, D., Uyama, E., and Rubinsztein, D.C. 2002. Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. J. Biol. Chem. 277(14): 12263-12269. doi:10.1074/jbc.M109633200. PMID:11796717.
8. Barnett, M.E., Nagy, M., Kedzierska, S., and Zolkiewski, M. 2005. The amino-terminal domain of ClpB supports binding to strongly aggregated proteins. J. Biol. Chem. 280(41): 34940-34945. doi:10.1074/jbc.M505653200. PMID:16076845.
9. Bartlett, A.I., and Radford, S.E. 2009. An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms. Nat. Struct. Mol. Biol. 16(6): 582-588. doi:10.1038/nsmb. 1592. PMID:19491935.
10. Baxa, U., Speransky, V., Steven, A.C., and Wickner, R.B. 2002. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl. Acad. Sci. U.S.A. 99(8): 5253-5260. doi:10.1073/pnas.082097899. PMID: 11959975.
11. Bence, N.F., Sampat, R.M., and Kopito, R.R. 2001. Impairment of the ubiquitin-proteasome system by protein aggregation. Science, 292(5521): 1552-1555. doi:10.1126/science.292.5521.1552. PMID:11375494.
12. Berson, J.F., Theos, A.C., Harper, D.C., Tenza, D., Raposo, G., and Marks, M.S. 2003. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161(3): 521-533. doi:10.1083/jcb.200302072. PMID:12732614.
13. Bösl, B., Grimminger, V., and Walter, S. 2005. Substrate binding to the molecular chaperone Hsp104 and its regulation by nucleotides. J. Biol. Chem. 280(46): 38170-38176. doi:10.1074/jbc.M506149200. PMID:16135516.
14. Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A., Jansen Steur, E.N., and Braak, E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 24(2): 197-211. doi:10.1016/S0197-4580(02)00065-9. PMID:12498954.
15. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H.M. 2007. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3(3): 186-191. doi:10.1016/j.jalz.2007.04.381. PMID:19595937.
16. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., et al. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 416(6880): 507-511. doi:10.1038/416507a. PMID:11932737.
17. Carmichael, J., Chatellier, J., Woolfson, A., Milstein, C., Fersht, A.R., and Rubinsztein, D.C. 2000. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 97(17): 9701-9705. doi:10.1073/pnas.170280697. PMID: 10920207.
18. Carulla, N., Caddy, G.L., Hall, D.R., Zurdo, J., Gairí, M., Feliz, M., et al. 2005. Molecular recycling within amyloid fibrils. Nature, 436(7050): 554-558. doi:10.1038/nature03986. PMID: 16049488.
19. Cashikar, A.G., Schirmer, E.C., Hattendorf, D.A., Glover, J.R., Ramakrishnan, M.S., Ware, D.M., and Lindquist, S.L. 2002. Defining a pathway of communication from the C-terminal peptide binding domain to the N-terminal ATPase domain in a AAA protein. Mol. Cell, 9(4): 751-760. doi:10.1016/S1097-2765(02)00499-9. PMID:11983167.
20. Cashikar, A.G., Duennwald, M., and Lindquist, S.L. 2005. A chaperone pathway in protein disaggregation. Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104. J. Biol. Chem. 280(25): 23869-23875. doi:10.1074/jbc.M502854200. PMID:15845535.
21. Caughey, B., and Lansbury, P.T. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26(1): 267-298. doi:10.1146/annurev.neuro.26.010302.081142. PMID: 12704221.
22. Chen, Q., Liu, J.B., Horak, K.M., Zheng, H., Kumarapeli, A.R., Li, J., et al. 2005. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ. Res. 97(10): 1018-1026. doi:10.1161/01.RES.0000189262.92896.0b. PMID:16210548.
23. Chernoff, Y.O., Lindquist, S.L., Ono, B., Inge-Vechtomov, S.G., and Liebman, S.W. 1995. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science, 268(5212): 880-884 . doi:10.1126/science.7754373. PMID:7754373.
24. Choi, W., Zibaee, S., Jakes, R., Serpell, L.C., Davletov, B., and Crowther, R.A., et al. 2004. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 576(3): 363-368. doi:10.1016/j.febslet.2004.09.038. PMID:15498564.
25. Cohen, E., Bieschke, J., Perciavalle, R.M., Kelly, J.W., and Dillin, A. 2006. Opposing activities protect against age-onset proteotoxicity. Science, 313(5793): 1604-1610. doi:10.1126/science.1124646. PMID:16902091.
26. Crowther, R.A., Daniel, S.E., and Goedert, M. 2000. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain. Neurosci. Lett. 292(2): 128-130. doi:10.1016/S0304-3940(00)01440- 3. PMID:10998565.
27. Cuervo, A.M. 2008. Autophagy and aging: keeping that old broom working. Trends Genet. 24(12): 604-612. doi:10.1016/j.tig.2008.10.002. PMID:18992957.
28. Dandoy-Dron, F., Bogdanova, A., Beringue, V., Bailly, Y., Tovey, M.G., and Laude, H., et al. 2006. Infection by ME7 prion is not modified in transgenic mice expressing the yeast chaperone Hsp104 in neurons. Neurosci. Lett. 405(3): 181-185. doi:10.1016/j.neulet.2006.05.066. PMID:16884849.
29. Dobson, C.M. 2003. Protein folding and misfolding. Nature, 426(6968): 884-890. doi:10.1038/nature02261. PMID:14685248.
30. Dorsey, E.R., Constantinescu, R., Thompson, J.P., Biglan, K.M., Holloway, R.G., Kieburtz, K., et al. 2007. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68(5): 384-386. doi:10.1212/01.wnl.0000247740.47667.03. PMID:17082464.
31. Douglas, P.M., Treusch, S., Ren, H.Y., Halfmann, R., Duennwald, M.L., Lindquist, S., and Cyr, D.M. 2008. Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc. Natl. Acad. Sci. U.S.A. 105(20): 7206-7211. doi:10.1073/pnas.0802593105. PMID:18480252.
32. Doyle, S.M., and Wickner, S. 2009. Hsp104 and ClpB: protein disaggregating machines. Trends Biochem. Sci. 34(1): 40-48. doi:10.1016/j.tibs.2008.09.010. PMID:19008106.
33. Doyle, S.M., Hoskins, J.R., and Wickner, S. 2007a. Collaboration between the ClpB AAA+ remodeling protein and the DnaK chaperone system. Proc. Natl. Acad. Sci. U.S.A. 104(27): 11138-11144. doi:10.1073/pnas. 0703980104. PMID:17545305.
34. Doyle, S.M., Shorter, J., Zolkiewski, M., Hoskins, J.R., Lindquist, S., and Wickner, S. 2007b. Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity. Nat. Struct. Mol. Biol. 14(2): 114-122. doi:10.1038/nsmb1198. PMID:17259993.
35. Eisenberg, D., Nelson, R., Sawaya, M.R., Balbirnie, M., Sambashivan, S., Ivanova, M.I., et al. 2006. The structural biology of protein aggregation diseases: Fundamental questions and some answers. Acc. Chem. Res. 39(9): 568-575. doi:10.1021/ar0500618. PMID:16981672.
36. Ellis, R.J., and Minton, A.P. 2006. Protein aggregation in crowded environments. Biol. Chem. 387(5): 485-497. doi:10.1515/BC.2006.064. PMID:16740119.
37. Englander, S.W., Mayne, L., and Krishna, M.M. 2007. Protein folding and misfolding: mechanism and principles. Q. Rev. Biophys. 40(4): 287-326. PMID:18405419.
38. Feigin, A., Kaplitt, M.G., Tang, C., Lin, T., Mattis, P., Dhawan, V., et al. 2007. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 104(49): 19559-19564. doi:10.1073/pnas.0706006104. PMID:18042721.
39. Forman, M.S., Trojanowski, J.Q., and Lee, V.M. 2004. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10(10): 1055-1063. doi:10.1038/nm1113. PMID:15459709.
40. Fowler, D.M., Koulov, A.V., Alory-Jost, C., Marks, M.S., Balch, W.E., and Kelly, J.W. 2006. Functional amyloid formation within mammalian tissue. PLoS Biol. 4(1): e6. doi:10.1371/journal.pbio.0040006. PMID:16300414.
41. Fowler, D.M., Koulov, A.V., Balch, W.E., and Kelly, J.W. 2007. Functional amyloid - from bacteria to humans. Trends Biochem. Sci. 32(5): 217-224. doi:10.1016/j.tibs.2007.03.003. PMID: 17412596.
42. Gestwicki, J.E., Crabtree, G.R., and Graef, I.A. 2004. Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation. Science, 306(5697): 865-869. doi:10.1126/science.1101262. PMID:15514157.
43. Gitler, A.D., and Shorter, J. 2007. Prime time for alpha-synuclein. J. Neurosci. 27(10): 2433-2434. doi:10.1523/JNEUROSCI.0094-07.2007. PMID:17344380.
44. Gitler, A.D., Bevis, B.J., Shorter, J., Strathearn, K.E., Hamamichi, S., Su, L.J., et al. 2008. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105(1): 145-150. doi:10.1073/pnas.0710685105. PMID:18162536.
45. Glenner, G.G., and Wong, C.W. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120(3): 885-890. doi:10.1016/S0006-291X(84)80190-4. PMID: 6375662.
46. Glover, J.R., and Lindquist, S. 1998. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell, 94(1): 73-82. doi:10.1016/S0092-8674(00)81223-4. PMID:9674429.
47. Glover, J.R., and Lum, R. 2009. Remodeling of protein aggregates by Hsp104. Protein Pept. Lett. 16(6): 587-597. doi:10.2174/ 092986609788490087. PMID:19519516.
48. Goloubinoff, P., Mogk, A., Zvi, A.P., Tomoyasu, T., and Bukau, B. 1999. Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network. Proc. Natl. Acad. Sci. U.S.A. 96(24): 13732-13737. doi:10.1073/pnas.96.24.13732. PMID:10570141.
49. Greenbaum, E.A., Graves, C.L., Mishizen-Eberz, A.J., Lupoli, M.A., Lynch, D.R., Englander, S.W., et al. 2005. The E46K mutation in alpha-synuclein increases amyloid fibril formation. J. Biol. Chem. 280(9): 7800-7807. doi:10.1074/jbc.M411638200. PMID:15632170.
50. Griswold, C.K., Masel, J., and Ú beda, F. 2009. Complex adaptations can drive the evolution of the capacitor [PSI], even with realistic rates of yeast sex. PLoS Genet. 5(6): e1000517. doi:10.1371/journal.pgen. 1000517. PMID:19521499.
51. Grundke-Iqbal, I., Iqbal, K., George, L., Tung, Y.C., Kim, K.S., and Wisniewski, H.M. 1989. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86(8): 2853-2857. doi:10.1073/pnas.86.8.2853. PMID:2649895.
52. Haass, C., and Selkoe, D.J. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8(2): 101-112. doi:10.1038/nrm2101. PMID:17245412.
53. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., et al. 2002. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346(16): 1185-1193. doi:10.1056/NEJMoa012616. PMID:11961146.
54. Haslberger, T., Weibezahn, J., Zahn, R., Lee, S., Tsai, F.T., Bukau, B., and Mogk, A. 2007. M domains couple the ClpB threading motor with the DnaK chaperone activity. Mol. Cell, 25(2): 247-260. doi:10.1016/j.molcel.2006. 11.008. PMID:17244532.
55. Haslberger, T., Zdanowicz, A., Brand, I., Kirstein, J., Turgay, K., Mogk, A., and Bukau, B. 2008. Protein disaggregation by the AAA+ chaperone ClpB involves partial threading of looped polypeptide segments. Nat. Struct. Mol. Biol. 15(6): 641-650. doi:10.1038/nsmb.1425. PMID:18488042.
56. Hattendorf, D.A., and Lindquist, S.L. 2002. Cooperative kinetics of both Hsp104 ATPase domains and interdomain communication revealed by AAA sensor-1 mutants. EMBO J. 21(1-2): 12-21. doi:10.1093/emboj/21.1.12. PMID:11782421.
57. Higurashi, T., Hines, J.K., Sahi, C., Aron, R., and Craig, E.A. 2008. Specificity of the J-protein Sis1 in the propagation of 3 yeast prions. Proc. Natl. Acad. Sci. U.S.A. 105(43): 16596-16601. doi:10.1073/pnas. 0808934105. PMID:18955697.
58. Hung, G.C., and Masison, D.C. 2006. N-terminal domain of yeast Hsp104 chaperone is dispensable for thermotolerance and prion propagation but necessary for curing prions by Hsp104 overexpression. Genetics, 173(2): 611-620. doi:10.1534/genetics.106.056820. PMID:16582428.
59. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. 1994. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron, 13(1): 45-53. doi:10.1016/0896-6273(94)90458-8. PMID: 8043280.
60. Johnson, B.S., Snead, D., Lee, J.J., McCaffery, J.M., Shorter, J., and Gitler, A.D. 2009. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284(30): 20329-20339. doi:10.1074/jbc.M109.010264. PMID:19465477.
61. Kaplitt, M.G., Feigin, A., Tang, C., Fitzsimons, H.L., Mattis, P., Lawlor, P.A., et al. 2007. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet, 369(9579): 2097-2105. doi:10.1016/S0140- 6736(07)60982-9. PMID: 17586305.
62. Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W., and Glabe, C.G. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 300(5618): 486-489. doi:10.1126/science.1079469. PMID:12702875.
63. Kholová, I., and Niessen, H.W. 2005. Amyloid in the cardiovascular system: a review. J. Clin. Pathol. 58(2): 125-133. doi:10.1136/jcp.2004. 017293. PMID:15677530.
64. King, O.D., and Masel, J. 2007. The evolution of bet-hedging adaptations to rare scenarios. Theor. Popul. Biol. 72(4): 560-575. doi:10.1016/j.tpb.2007.08.006. PMID:17915273.
65. Knowles, T.P., Fitzpatrick, A.W., Meehan, S., Mott, H.R., Vendruscolo, M., Dobson, C.M., and Welland, M.E. 2007. Role of intermolecular forces in defining material properties of protein nanofibrils. Science, 318(5858): 1900-1903. doi:10.1126/science.1150057. PMID:18096801.
66. Kobayashi, T., Manno, A., and Kakizuka, A. 2007. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells, 12(7): 889-901. doi:10.1111/j.1365-2443. 2007.01099.x. PMID:17584300.
67. Kramer, G., Boehringer, D., Ban, N., and Bukau, B. 2009. The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins. Nat. Struct. Mol. Biol. 16(6): 589-597. doi:10.1038/nsmb.1614. PMID:19491936.
68. Krishnan, R., and Lindquist, S.L. 2005. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature, 435(7043): 765-772. doi:10.1038/nature03679. PMID:15944694.
69. LaFerla, F.M., Green, K.N., and Oddo, S. 2007. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8(7): 499-509. doi:10.1038/nrn2168. PMID:17551515.
70. Lansbury, P.T., Jr., and Caughey, B. 1995. The chemistry of scrapie infection: implications of the 'ice 9' metaphor. Chem. Biol. 2(1): 1-5. doi:10.1016/1074-5521(95)90074-8. PMID:9383397.
71. Larsen, K.E., Schmitz, Y., Troyer, M.D., Mosharov, E., Dietrich, P., Quazi, A.Z., et al. 2006. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26(46): 11915-11922. doi:10.1523/JNEUROSCI.3821- 06.2006. PMID: 17108165.
72. Lashuel, H.A., Hartley, D., Petre, B.M., Walz, T., and Lansbury, P.T., Jr. 2002. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature, 418(6895): 291. doi:10.1038/418291a. PMID:12124613.
73. Lee, S., Sowa, M.E., Watanabe, Y.H., Sigler, P.B., Chiu, W., Yoshida, M., and Tsai, F.T. 2003. The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state. Cell, 115(2): 229-240. doi:10.1016/S0092-8674(03)00807-9. PMID:14567920.
74. Lee, J.W., Beebe, K., Nangle, L.A., Jang, J., Longo-Guess, C.M., Cook, S.A., et al. 2006. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature, 443(7107): 50-55. doi:10.1038/nature05096. PMID:16906134.
75. Lee, S., Choi, J.M., and Tsai, F.T. 2007. Visualizing the ATPase cycle in a protein disaggregating machine: structural basis for substrate binding by ClpB. Mol. Cell, 25(2): 261-271. doi:10.1016/j.molcel.2007.01.002. PMID:17244533.
76. Legname, G., Nguyen, H.O., Peretz, D., Cohen, F.E., DeArmond, S.J., and Prusiner, S.B. 2006. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl. Acad. Sci. U.S.A. 103(50): 19105-19110. doi:10.1073/pnas.0608970103. PMID:17142317.
77. Lesné, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., et al. 2006. A specific amyloid-beta protein assembly in the brain impairs memory. Nature, 440(7082): 352-357. doi:10.1038/nature04533. PMID:16541076.
78. Lo Bianco, C., Ridet, J.L., Schneider, B.L., Deglon, N., and Aebischer, P. 2002. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 99(16): 10813-10818. doi:10.1073/pnas.152339799. PMID:12122208.
79. Lo Bianco, C., Schneider, B.L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T., and Aebischer, P. 2004. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 101(50): 17510-17515. doi:10.1073/pnas.0405313101. PMID:15576511.
80. Lo Bianco, C., Shorter, J., Régulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S., and Aebischer, P. 2008. Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J. Clin. Invest. 118(9): 3087-3097. doi:10.1172/JCI35781. PMID:18704197.
81. Lum, R., Tkach, J.M., Vierling, E., and Glover, J.R. 2004. Evidence for an unfolding/threading mechanism for protein disaggregation by Saccharomyces cerevisiae Hsp104. J. Biol. Chem. 279(28): 29139-29146. doi:10.1074/jbc.M403777200. PMID: 15128736.
82. Lum, R., Niggemann, M., and Glover, J.R. 2008. Peptide and protein binding in the axial channel of Hsp104. Insights into the mechanism of protein unfolding. J. Biol. Chem. 283(44): 30139-30150. doi:10.1074/jbc. M804849200. PMID:18755692.
83. Mackay, R.G., Helsen, C.W., Tkach, J.M., and Glover, J.R. 2008. The C-terminal extension of Saccharomyces cerevisiae Hsp104 plays a role in oligomer assembly. Biochemistry, 47(7): 1918-1927. doi:10.1021/bi701714s. PMID:18197703.
84. Maguire, A.M., Simonelli, F., Pierce, E.A., Pugh, E.N., Jr., Mingozzi, F., Bennicelli, J., et al. 2008. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358(21): 2240-2248. doi:10.1056/NEJMoa0802315. PMID: 18441370.
85. Maji, S.K., Perrin, M.H., Sawaya, M.R., Jessberger, S., Vadodaria, K., Rissman, R.A., et al. 2009. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science, 325(5938): 328-332. doi:10.1126/science.1173155. PMID:19541956.
86. Martins, I.C., Kuperstein, I., Wilkinson, H., Maes, E., Vanbrabant, M., Jonckheere, W., et al. 2008. Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27(1): 224-233. doi:10.1038/sj.emboj.7601953. PMID:18059472.
87. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., and Beyreuther, K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82(12): 4245-4249. doi:10.1073/pnas.82.12.4245. PMID:3159021.
88. Merlini, G., and Westermark, P. 2004. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J. Intern. Med. 255(2): 159-178. doi:10.1046/j.1365-2796.2003. 01262.x. PMID:14746554.
89. Meyer, H., and Popp, O. 2008. Role(s) of Cdc48/p97 in mitosis. Biochem. Soc. Trans. 36(Pt 1): 126-130. doi:10.1042/BST0360126. PMID:18208399.
90. Meyer-Luehmann, M., Spires-Jones, T.L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., et al. 2008. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature, 451(7179): 720-724. doi:10.1038/nature06616. PMID:18256671.
91. Meyer-Langen, H., and Bukau, B. 1999. Identification of thermolabile Escherichia coli proteins: prevention and reversion of aggregation by DnaK and ClpB. EMBO J. 18(24): 6934-6949. doi:10.1093/emboj/18.24.6934. PMID:10601016.
92. Mogk, A., Tomoyasu, T., Goloubinoff, P., Rüdiger, S., Röder, D., Langen, H., and Bukau, B. 1999. Identification of thermolabile Escherichia coli proteins: prevention and reversion of aggregation by DnaK and ClpB. EMBO J. 18(24): 6934-6949. doi:10.1093/emboj/18.24.6934. PMID:10601016.
93. Moore, D.J., West, A.B., Dawson, V.L., and Dawson, T.M. 2005. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28(1): 57-87. doi:10.1146/annurev.neuro.28.061604.135718. PMID:16022590.
94. Morimoto, R.I. 2006. Stress, aging, and neurodegenerative disease. N. Engl. J. Med. 355(21): 2254-2255. doi:10.1056/NEJMcibr065573. PMID:17124027.
95. Mosser, D.D., Ho, S., and Glover, J.R. 2004. Saccharomyces cerevisiae Hsp104 enhances the chaperone capacity of human cells and inhibits heat stress-induced proapoptotic signaling. Biochemistry, 43(25): 8107-8115. doi:10.1021/bi0493766. PMID: 15209506.
96. Narayanan, S., Walter, S., and Reif, B. 2006. Yeast prion-protein, sup35, fibril formation proceeds by addition and substraction of oligomers. ChemBioChem, 7(5): 757-765. doi:10.1002/cbic.200500382. PMID:16570324.
97. Nekooki-Machida, Y., Kurosawa, M., Nukina, N., Ito, K., Oda, T., and Tanaka, M. 2009. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 106(24): 9679-9684. doi:10.1073/pnas.0812083106. PMID:19487684.
98. Nelson, R., and Eisenberg, D. 2006. Structural models of amyloid-like fibrils. Adv. Protein Chem. 73: 235-282. doi:10.1016/S0065-3233(06)73008- X. PMID:17190616.
99. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., et al. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796): 130-133. doi:10.1126/science.1134108. PMID:17023659.
100. Nishikori, S., Yamanaka, K., Sakurai, T., Esaki, M., and Ogura, T. 2008. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat. Genes Cells, 13(8): 827-838. doi:10.1111/j.1365-2443.2008.01214.x. PMID: 18782221.
101. Parsell, D.A., and Lindquist, S. 1993. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet. 27(1): 437-496. doi:10.1146/annurev.ge.27.120193. 002253. PMID:8122909.
102. Parsell, D.A., Taulien, J., Lindquist, S., Viitanen, P., Jaenicke, R., Horwich, A., et al. 1993. The role of heat-shock proteins in thermotolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 339(1289): 279-285, discussion 285-286. doi:10.1098/rstb.1993.0026. PMID:8098532.
103. Parsell, D.A., Kowal, A.S., and Lindquist, S. 1994a. Saccharomyces cerevisiae Hsp104 protein. Purification and characterization of ATP-induced structural changes. J. Biol. Chem. 269(6): 4480-4487. PMID:8308017.
104. Parsell, D.A., Kowal, A.S., Singer, M.A., and Lindquist, S. 1994b. Protein disaggregation mediated by heat-shock protein Hsp104. Nature, 372(6505): 475-478. doi:10.1038/372475a0. PMID: 7984243.
105. Perrin, V., Régulier, E., Abbas-Terki, T., Hassig, R., Brouillet, E., Aebischer, P., et al. 2007. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Mol. Ther. 15(5): 903-911. doi:10.1038/mt.sj.6300141. PMID: 17375066.
106. Petkova, A.T., Leapman, R.D., Guo, Z., Yau, W.M., Mattson, M.P., and Tycko, R. 2005. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science, 307(5707): 262-265. doi:10.1126/science. 1105850. PMID: 15653506.
107. Powers, E.T., Morimoto, R.I., Dillin, A., Kelly, J.W., and Balch, W.E. 2009. Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78(1): 959-991. doi:10.1146/annurev.biochem.052308. 114844. PMID:19298183.
108. Queitsch, C., Hong, S.W., Vierling, E., and Lindquist, S. 2000. Heat shock protein 101 plays a crucial role in thermotolerance in Arabidopsis. Plant Cell, 12(4): 479-492. doi:10.1105/tpc.12.4.479. PMID:10760238.
109. Roberson, E.D., and Mucke, L. 2006. 100 years and counting: prospects for defeating Alzheimer's disease. Science, 314(5800): 781-784. doi:10.1126/science.1132813. PMID:17082448.
110. Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., et al. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4(10): 1157-1165. doi:10.1038/2654. PMID:9771749.
111. Sanchez, Y., and Lindquist, S.L. 1990. HSP104 required for induced thermotolerance. Science, 248(4959): 1112-1115. doi:10.1126/science. 2188365. PMID:2188365.
112. Sanchez, Y., Taulien, J., Borkovich, K.A., and Lindquist, S. 1992. Hsp104 is required for tolerance to many forms of stress. EMBO J. 11(6): 2357-2364. PMID:1600951.
113. Satyal, S.H., Schmidt, E., Kitagawa, K., Sondheimer, N., Lindquist, S., Kramer, J.M., and Morimoto, R.I. 2000. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 97(11): 5750-5755. doi:10.1073/pnas.100107297. PMID:10811890.
114. Savistchenko, J., Krzewska, J., Fay, N., and Melki, R. 2008. Molecular chaperones and the assembly of the prion Ure2p in vitro. J. Biol. Chem. 283(23): 15732-15739. doi:10.1074/jbc.M800728200. PMID:18400756.
115. Schaupp, A., Marcinowski, M., Grimminger, V., Bösl, B., and Walter, S. 2007. Processing of proteins by the molecular chaperone Hsp104. J. Mol. Biol. 370(4): 674-686. doi:10.1016/j.jmb.2007.04.070. PMID:17543332.
116. Schirmer, E.C., and Lindquist, S. 1997. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc. Natl. Acad. Sci. U.S.A. 94(25): 13932-13937. doi:10.1073/pnas.94.25.13932. PMID:9391130.
117. Schirmer, E.C., Queitsch, C., Kowal, A.S., Parsell, D.A., and Lindquist, S. 1998. The ATPase activity of Hsp104, effects of environmental conditions and mutations. J. Biol. Chem. 273(25): 15546-15552. doi:10.1074/jbc.273.25. 15546. PMID:9624144.
118. Schirmer, E.C., Ware, D.M., Queitsch, C., Kowal, A.S., and Lindquist, S.L. 2001. Subunit interactions influence the biochemical and biological properties of Hsp104. Proc. Natl. Acad. Sci. U.S.A. 98(3): 914-919. doi:10.1073/pnas.031568098. PMID: 11158570.
119. Schlieker, C., Weibezahn, J., Patzelt, H., Tessarz, P., Strub, C., Zeth, K., et al. 2004. Substrate recognition by the AAA+ chaperone ClpB. Nat. Struct. Mol. Biol. 11(7): 607-615. doi:10.1038/nsmb787. PMID:15208691.
120. Shorter, J. 2008. Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals, 16(1): 63-74. doi:10.1159/000109760. PMID:18097161.
121. Shorter, J., and Lindquist, S. 2004. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science, 304(5678): 1793-1797. doi:10.1126/science.1098007. PMID: 15155912.
122. Shorter, J., and Lindquist, S. 2005a. Navigating the ClpB channel to solution. Nat. Struct. Mol. Biol. 12(1): 4-6. doi:10.1038/nsmb0105-4. PMID:15689967.
123. Shorter, J., and Lindquist, S. 2005b. Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet. 6(6): 435-450. doi:10.1038/nrg1616. PMID:15931169.
124. Shorter, J., and Lindquist, S. 2006. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell, 23(3): 425-438. doi:10.1016/j.molcel.2006.05.042. PMID:16885031.
125. Shorter, J., and Lindquist, S. 2008. Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J. 27(20): 2712-2724. doi:10.1038/emboj.2008.194. PMID:18833196.
126. Si, K., Lindquist, S., and Kandel, E.R. 2003. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell, 115(7): 879-891. doi:10.1016/S0092-8674(03)01020-1. PMID:14697205.
127. Skovronsky, D.M., Lee, V.M., and Trojanowski, J.Q. 2006. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1(1): 151-170. doi:10.1146/annurev. pathol.1.110304.100113. PMID:18039111.
128. Smith, J.F., Knowles, T.P., Dobson, C.M., Macphee, C.E., and Welland, M.E. 2006. Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 103(43): 15806-15811. doi:10.1073/pnas.0604035103. PMID: 17038504.
129. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., and Goedert, M. 1997. Alpha-synuclein in Lewy bodies. Nature, 388(6645): 839-840. doi:10.1038/42166. PMID: 9278044.
130. Spillantini, M.G., Crowther, R.A., Jakes, R., Cairns, N.J., Lantos, P.L., and Goedert, M. 1998. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251(3): 205-208. doi:10.1016/S0304-3940(98)00504-7. PMID:9726379.
131. Squires, C.L., Pedersen, S., Ross, B.M., and Squires, C. 1991. ClpB is the Escherichia coli heat shock protein F84.1. J. Bacteriol. 173(14): 4254-4262. PMID:2066329.
132. Stoessl, A.J. 2007. Gene therapy for Parkinson's disease: early data. Lancet, 369(9579): 2056-2058. doi:10.1016/S0140-6736(07)60957-X. PMID:17586286.
133. Sunde, M., and Blake, C. 1997. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50: 123-159. doi:10.1016/S0065-3233(08)60320-4. PMID: 9338080.
134. Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., and Blake, C.C. 1997. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273(3): 729-739. doi:10.1006/jmbi.1997.1348. PMID:9356260.
135. Sweeny, E.A., and Shorter, J. 2008. Prion proteostasis: Hsp104 meets its supporting cast. Prion, 2(4): 135-140. PMID: 19242125.
136. Tanaka, M., Collins, S.R., Toyama, B.H., and Weissman, J.S. 2006. The physical basis of how prion conformations determine strain phenotypes. Nature, 442(7102): 585-589. doi:10.1038/nature04922. PMID:16810177.
137. Taylor, J.P., Hardy, J., and Fischbeck, K.H. 2002. Toxic proteins in neurodegenerative disease. Science, 296(5575): 1991-1995. doi:10.1126/science.1067122. PMID:12065827.
138. Tessarz, P., Mogk, A., and Bukau, B. 2008. Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation. Mol. Microbiol. 68(1): 87-97. doi:10.1111/j.1365-2958.2008.06135.x. PMID:18312264.
139. Tessier, P.M., and Lindquist, S. 2007. Prion recognition elements govern nucleation, strain specificity and species barriers. Nature, 447(7144): 556-561. doi:10.1038/nature05848. PMID:17495929.
140. Thoms, S. 2002. Cdc48 can distinguish between native and non-native proteins in the absence of cofactors. FEBS Lett. 520(1-3): 107-110. doi:10.1016/S0014-5793(02)02777-1. PMID: 12044880.
141. Tipton, K.A., Verges, K.J., and Weissman, J.S. 2008. In vivo monitoring of the prion replication cycle reveals a critical role for Sis1 in delivering substrates to Hsp104. Mol. Cell, 32(4): 584-591. doi:10.1016/j.molcel. 2008.11.003. PMID:19026788.
142. Toyama, B.H., Kelly, M.J., Gross, J.D., and Weissman, J.S. 2007. The structural basis of yeast prion strain variants. Nature, 449(7159): 233-237. doi:10.1038/nature06108. PMID:17767153.
143. Treusch, S., Cyr, D.M., and Lindquist, S. 2009. Amyloid deposits: protection against toxic protein species? Cell Cycle, 8(11): 1668-1674. PMID:19411847.
144. True, H.L., and Lindquist, S.L. 2000. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature, 407(6803): 477-483. doi:10.1038/35035005. PMID:11028992.
145. Tyedmers, J., Madariaga, M.L., Lindquist, S., and Weissman, J. 2008. Prion switching in response to environmental stress. PLoS Biol. 6(11): e294. doi:10.1371/journal.pbio.0060294. PMID: 19067491.
146. Vacher, C., Garcia-Oroz, L., and Rubinsztein, D.C. 2005. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 14(22): 3425-3433. doi:10.1093/hmg/ddi372. PMID:16204350.
147. Varshavsky, A. 2005. Regulated protein degradation. Trends Biochem. Sci. 30(6): 283-286. doi:10.1016/j.tibs.2005.04.005. PMID:15950869.
148. Vashist, S., and Ng, D.T. 2004. Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J. Cell Biol. 165(1): 41-52. doi:10.1083/jcb.200309132. PMID: 15078901.
149. Vembar, S.S., and Brodsky, J.L. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9(12): 944-957. doi:10.1038/nrm2546. PMID:19002207.
150. Wang, H., Duennwald, M.L., Roberts, B.E., Rozeboom, L.M., Zhang, Y.L., Steele, A.D., et al. 2008. Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs. Proc. Natl. Acad. Sci. U.S.A. 105(20): 7159-7164. doi:10.1073/pnas.0801934105. PMID:18480256.
151. Weibezahn, J., Tessarz, P., Schlieker, C., Zahn, R., Maglica, Z., Lee, S., et al. 2004. Thermotolerance requires refolding of aggregated proteins by substrate translocation through the central pore of ClpB. Cell, 119(5): 653-665. doi:10.1016/j.cell.2004.11.027. PMID:15550247.
152. Weibezahn, J., Schlieker, C., Tessarz, P., Mogk, A., and Bukau, B. 2005. Novel insights into the mechanism of chaperone-assisted protein disaggregation. Biol. Chem. 386(8): 739-744. doi:10.1515/BC.2005.086. PMID:16201868.
153. Wendler, P., and Saibil, H.R. 2010. Cryo-electron microscopy structures of Hsp100 proteins-crowbars in or out. Biochem. Cell Biol. 88: this issue.
154. Wendler, P., Shorter, J., Plisson, C., Cashikar, A.G., Lindquist, S., and Saibil, H.R. 2007. Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104. Cell, 131(7): 1366-1377. doi:10.1016/j.cell.2007.10.047. PMID:18160044.
155. Wendler, P., Shorter, J., Snead, D., Plisson, C., Clare, D.K., Lindquist, S., and Saibil, H.R. 2009. Motor mechanism for protein threading through Hsp104. Mol. Cell, 34(1): 81-92. doi:10.1016/j.molcel.2009.02.026. PMID:19362537.
156. Wenk, G.L. 2003. Neuropathologic changes in Alzheimer's disease. J. Clin. Psychiatry, 64(Suppl 9): 7-10. PMID:12934968.
157. Werbeck, N.D., Schlee, S., and Reinstein, J. 2008. Coupling and dynamics of subunits in the hexameric AAA+ chaperone ClpB. J. Mol. Biol. 378(1): 178-190. doi:10.1016/j.jmb.2008.02.026. PMID:18343405.
158. Wertkin, A.M., Turner, R.S., Pleasure, S.J., Golde, T.E., Younkin, S.G., Trojanowski, J.Q., and Lee, V.M. 1993. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc. Natl. Acad. Sci. U.S.A. 90(20): 9513-9517. doi:10.1073/pnas.90.20.9513. PMID: 8415732.
159. Young, J.C., Agashe, V.R., Siegers, K., and Hartl, F.U. 2004. Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 5(10): 781-791. doi:10.1038/nrm1492. PMID:15459659.